Pharmacological therapy for idiopathic pulmonary fibrosis: Past, present, and future

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1771-1777

  Muson, R J ^a   Schwarz, M I ^a   Hunninghake, G W ^a   Musson, R A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; BETA INTERFERON; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON; ICOSANOID; KERATINOCYTE GROWTH FACTOR; PIRFENIDONE; RELAXIN; SURAMIN;

CONFERENCE PAPER; DRUG RESEARCH; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; CONSENSUS DEVELOPMENT; PATHOPHYSIOLOGY;

HUMANS; PULMONARY FIBROSIS;

EID: 0033227185     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9903009     Document Type: Conference Paper

References (65)